NCT02639676View on ClinicalTrials.gov

Anti-Angiogenic Preeclampsia Milieu Impairs Infant Lung and Vascular Development

CompletedOBSERVATIONAL
Enrollment

292

Participants

Timeline

Start Date

February 11, 2016

Primary Completion Date

November 17, 2020

Study Completion Date

November 17, 2020

Conditions
Preeclampsia
Interventions
OTHER

Diffusion Lung Capacity (DLCO), Vascular Challenge, Video Imaging, Specimen Collections

Trial Locations (1)

46202

Riley Hospital for Children, Indianapolis

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

National Institutes of Health (NIH)

NIH

lead

Indiana University

OTHER

NCT02639676 - Anti-Angiogenic Preeclampsia Milieu Impairs Infant Lung and Vascular Development | Biotech Hunter | Biotech Hunter